Bastian N Ruijter

4PUBLICATIONS
25CO-AUTHORS
Haematological tumoursPredictive and prognostic markersBehavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 08, 2024
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel

|Sep 12, 2023
Primary sclerosing cholangitis and other risk factors for post-transplant lymphoproliferative disease after liver transplantation in adults.

Bastian N Ruijter, Maarten E Tushuizen, Danny van der Helm

|Jan 16, 2023
Epstein-Barr Viral Load Monitoring Strategy and the Risk for Posttransplant Lymphoproliferative Disease in Adult Liver Transplantation : A Cohort Study.

Bastian N Ruijter, Ron Wolterbeek, Mitchell Hew

|Oct 04, 2022
Tacrolimus 4-hour monitoring in liver transplant patients is non-inferior to trough monitoring: The randomized controlled FK04 trial.

Bastian N Ruijter, Maarten E Tushuizen, Dirk J A R Moes

Pageof 1

Frequent Collaborators

2 joint publications

Bart van Hoek

1 joint publications

Marjolein van Reeven

1 joint publications

Danny van der Helm

1 joint publications

Bart van Hoek